Canadian regulatory agency Health Canada has issued a warning that the Yasmin line of birth control pills carries up to three times the risk of blood clots compared to other oral contraceptives, according to a Canadian Broadcasting Corporation report.
Health Canada came to that conclusion after a safety review of contraceptives containing the synthetic hormone drospirenone, which include read more.... -->
continue reading...
The $610.5 million Bayer set aside for Yasmin-related lawsuits this quarter is to pay the company’s costs beyond what insurance will cover for legal fees and accords, including cases that haven’t been settled, Bloomberg reports. The German drug maker isn’t disclosing the amount of its insurance coverage.
That $610.5 million indicates that the company is anticipating more payouts from its Yasmin line of birth control pills, because that amount is more ...
continue reading...
Bayer’s second quarter earnings are down, largely because of costs associated with settling lawsuits from consumers who claim the pharmaceutical giant’s Yasmin line of birth control pills caused health problems, the Pittsburgh Post Gazette reports.
Despite the lagging profits, however, the company said global sales for the quarter jumped by 10 percent to a record $12.5 billion on strong performances by all three of the company’s business segments. Crop sciences revenues ...
continue reading...According to a story in the U.K. newspaper Daily Express, a study found that people who snore are three times more likely to suffer a potentially fatal blood clot.
The study, led by a team of researchers in Taiwan, found that patients diagnosed with the snoring-related condition sleep apnea were three times as likely to develop a deep vein thrombosis – or a blood clot in one of the deeper veins, ...
continue reading...According to a Bloomberg report, Bayer has said that settlements of U.S. lawsuits over its Yasmin line of birth control pills have reached more than $402 million.
The German pharmaceutical giant has resolved almost 1,900 cases involving allegations that its contraceptives caused potentially deadly blood clots, the company said this week in a stockholders’ newsletter. Bayer said it has paid $402.6 million in settlements of one category of clot cases, for ...
continue reading...Pharmaceutical giant Bayer is facing legal action from thousands of plaintiffs who claim they or their loved ones have been injured by the Yasmin line of oral contraceptives.
The complaints about the Yasmin line of contraceptives cite a number of studies indicating that birth control pills with the compound drospirenone carry up to three times the risk of potentially fatal blood clots ...
continue reading...
